MHC class I plays a critical role in the immune defense against viruses and tumors by presenting antigens to CD8 T cells. An NLR protein, class II transactivator (CIITA), is a key regulator of MHC class II gene expression that associates and cooperates with transcription factors in the MHC class II promoter. Although CIITA also transactivates MHC class I gene promoters, loss of CIITA in humans and mice results in the severe reduction of only MHC class II expression, suggesting that additional mechanisms regulate the expression of MHC class I. Here, we identify another member of the NLR protein family, NLRC5, as a transcriptional regulator of MHC class I genes. Similar to CIITA, NLRC5 is an IFN-gamma-inducible nuclear protein, and the expres...
NLRC5, a member of the NOD-like receptor (NLR) protein family, has recently been characterized as th...
Purpose:Downregulation of MHC class I (MHC-I) is a common immune evasion strategy of many cancers. S...
The recent use of T cell-based cancer immunotherapies, such as adoptive T-cell transfer and checkpoi...
Major histocompatibility complex (MHC) class I and class II molecules play critical roles in the act...
Recent evidence demonstrates a key role for the nucleotide-binding oligomerization domain-like recep...
Most of the nucleotide-binding domain, leucine-rich repeat (NLR) proteins regulate responses to micr...
<div><p>MHC class II (MHCII) genes are transactivated by the NOD-like receptor (NLR) family member C...
Purpose/Objective: NLRs are intracellular proteins involved in sensing pathogen- and danger-associat...
Nucleotide-binding oligomerization domain-like receptors (NLRs) are intracellular proteins involved ...
Nucleotide-binding oligomerization domain-like receptors (NLRs) are intracellular proteins involved ...
Nucleotide-binding oligomerization domain-like receptors (NLRs) are intracellular proteins involved ...
Major histocompatibility complex (MHC) molecules are of crucial importance for the immune system to ...
The MHC class I pathway, presenting endogenously derived peptides to T lymphocytes, is hijacked in m...
MHC class II (MHCII) genes are transactivated by the NOD-like receptor (NLR) family member CIITA, wh...
Nucleotide-binding domain and leucine-rich repeat containing receptors (NLRs) are intracellular prot...
NLRC5, a member of the NOD-like receptor (NLR) protein family, has recently been characterized as th...
Purpose:Downregulation of MHC class I (MHC-I) is a common immune evasion strategy of many cancers. S...
The recent use of T cell-based cancer immunotherapies, such as adoptive T-cell transfer and checkpoi...
Major histocompatibility complex (MHC) class I and class II molecules play critical roles in the act...
Recent evidence demonstrates a key role for the nucleotide-binding oligomerization domain-like recep...
Most of the nucleotide-binding domain, leucine-rich repeat (NLR) proteins regulate responses to micr...
<div><p>MHC class II (MHCII) genes are transactivated by the NOD-like receptor (NLR) family member C...
Purpose/Objective: NLRs are intracellular proteins involved in sensing pathogen- and danger-associat...
Nucleotide-binding oligomerization domain-like receptors (NLRs) are intracellular proteins involved ...
Nucleotide-binding oligomerization domain-like receptors (NLRs) are intracellular proteins involved ...
Nucleotide-binding oligomerization domain-like receptors (NLRs) are intracellular proteins involved ...
Major histocompatibility complex (MHC) molecules are of crucial importance for the immune system to ...
The MHC class I pathway, presenting endogenously derived peptides to T lymphocytes, is hijacked in m...
MHC class II (MHCII) genes are transactivated by the NOD-like receptor (NLR) family member CIITA, wh...
Nucleotide-binding domain and leucine-rich repeat containing receptors (NLRs) are intracellular prot...
NLRC5, a member of the NOD-like receptor (NLR) protein family, has recently been characterized as th...
Purpose:Downregulation of MHC class I (MHC-I) is a common immune evasion strategy of many cancers. S...
The recent use of T cell-based cancer immunotherapies, such as adoptive T-cell transfer and checkpoi...